Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CDK17 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
NF1P9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FNIP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SERPINB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AFF4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VCPKMT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LCOR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UBR2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
ZNF107 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DBR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IAH1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF91 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAPGEF6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF791 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NPAT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ITM2B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HFE - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SMAD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on